Article
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics.
Clinical pharmacology and therapeutics - 1 Mar 2006
Katz David A, Carr Robert, Grimm David R, Xiong Hao, Holley-Shanks Rhonda, Mueller Toby, Leake Brenda, Wang Qiang, Han Lixin, Wang Perry G, Edeki Timi, Sahelijo Leonardo, Doan Thao, Allen Andrew, Spear Brian B, Kim Richard B
Abstract excerpt
OBJECTIVE: Our objective was to learn whether genetic polymorphisms of metabolic enzymes or transport proteins provide a mechanistic understanding of the in vivo disposition of atrasentan, a selective endothelin A receptor antagonist. METHODS: Atrasentan uptake was measured in HeLa cells transfected to express major alleles of organic anion transporting polypeptide 1B1 (OATP1B1). The results were used to classify...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
